- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07602660
Remineralization Potential of Bioactive Varnish
May 16, 2026 updated by: Mazin Mohamed Ibrahim, Future University in Egypt
Remineralization Potential of Bioactive Varnish Versus Sodium Fluoride Varnish in Management of White Spot Lesions: Randomized Controlled Trial
This randomized controlled trial is held to investigate the effectiveness of two remineralizing agents surface pre-reacted glass-ionomer (S-PRG) filler and fluoride in management of white spot lesions.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Surface pre-reacted glass-ionomer (S-PRG) technology represents a newer bioactive approach that extends beyond the effects of fluoride alone.
S-PRG fillers release multiple ions, including fluoride, strontium, sodium, silicate, borate, and aluminum, which act synergistically to promote remineralization, buffer acidic conditions, and inhibit bacterial activity In vitro and clinical evidence indicates that S-PRG-containing materials promote enamel remineralization and lesion stabilization, as laboratory studies have shown enhanced subsurface lesion repair, reduced lesion depth, and improved enamel surface morphology compared with controls, while clinical applications of PRG Barrier Coat have demonstrated significant reductions in white spot lesion area and increased enamel hardness for up to one year
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients within 16-35 years of age.
- Each patient has 4 or more WSLs
- Mild and moderate WSLs.
- Good oral hygiene and willing patients who can attend study visits.
- Symmetrical number of permanent teeth in each arch (mesial to second molars).
Exclusion Criteria:
- Active carious lesions.
- Labial surface restorations.
- Intrinsic and extrinsic stains.
- Patients who have a significant medical history or if they are smokers.
- Patients who participated in clinical study during the preceding six months of the start of this trial.
- Criteria for discontinuation; Mortality and acquiring severe debilitating disease.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: S-PRG barrier coat
varnish containing Surface pre-reacted glass-ionomer technology
|
varnish containing Surface pre-reacted glass-ionomer technology
|
|
Active Comparator: Profluorid Varnish
Fluoride varnish
|
Fluoride varnish
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients tooth caries lesion state
Time Frame: 6 months
|
FDI Criteria (Visual examination of active caries lesion)
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients' tooth color change
Time Frame: 6 months
|
VITA Easy Shade (ΔE)
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Study Registration Dates
First Submitted
May 16, 2026
First Submitted That Met QC Criteria
May 16, 2026
First Posted (Actual)
May 22, 2026
Study Record Updates
Last Update Posted (Actual)
May 22, 2026
Last Update Submitted That Met QC Criteria
May 16, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 5-2026
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on White Spot Lesion
-
Mansoura UniversityActive, not recruiting
-
Jordan University of Science and TechnologyActive, not recruitingWhite Spot Lesion of ToothJordan
-
King Abdullah University HospitalJordan University of Science and TechnologyActive, not recruitingWhite Spot LesionJordan
-
Al-Azhar UniversityEnrolling by invitation
-
Texas A&M UniversityCompletedWhite Spot LesionUnited States
-
Izmir Katip Celebi UniversityCompletedRemineralization | White Spot LesionTurkey
-
Cairo UniversityNot yet recruiting
-
Universitat Internacional de CatalunyaCompleted
-
EgymedicalpediaCompleted
-
Hams Hamed AbdelrahmanCompletedWhite Spot LesionEgypt
Clinical Trials on S-PRG barrier coat
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityNot yet recruitingWhite Spot Lesion of Tooth
-
Nahda UniversityCompleted
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityNot yet recruitingCaries, Dental | Remineralization | White Spot Lesion
-
Al-Azhar UniversityEnrolling by invitation
-
Cairo UniversityCompleted
-
Ain Shams UniversityRecruitingWhite Spot Lesions [Initial Caries] on Smooth Surface of ToothEgypt
-
Cairo UniversityCompleted
-
Eman Omar ElfaroukNot yet recruiting